Goat Polyclonal KDM2A antibody. Suitable for WB, IHC-P and reacts with Human samples. Cited in 3 publications. Immunogen corresponding to Synthetic Peptide within Human KDM2A aa 400-500.
View Alternative Names
CXXC8, FBL11, FBL7, FBXL11, JHDM1A, KIAA1004, KDM2A, Lysine-specific demethylase 2A, CXXC-type zinc finger protein 8, F-box and leucine-rich repeat protein 11, F-box protein FBL7, F-box protein Lilina, F-box/LRR-repeat protein 11, JmjC domain-containing histone demethylation protein 1A, [Histone-H3]-lysine-36 demethylase 1A
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-KDM2A antibody (AB174693)
Immunohistochemical analysis of formalin-fixed, paraffin-embedded Human small intestine tissue labeling KDM2A with ab174693 at 5 μg/ml.
- WB
Supplier Data
Western blot - Anti-KDM2A antibody (AB174693)
Primary incubation was 1 hour.
All lanes:
Western blot - Anti-KDM2A antibody (ab174693) at 0.5 µg/mL
All lanes:
Human uterus lysate (in RIPA buffer) at 35 µg
Predicted band size: 133 kDa
Observed band size: 140 kDa
true
Reactivity data
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (3)
Recent publications for all applications. Explore the full list and refine your search
Head & neck 45:225-236 PubMed36268878
2022
Applications
Unspecified application
Species
Unspecified reactive species
Artificial cells, nanomedicine, and biotechnology 47:2891-2899 PubMed31307234
2019
Applications
Unspecified application
Species
Unspecified reactive species
OncoTargets and therapy 11:6383-6394 PubMed30323616
2018
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com